Nimesulide and patient safety: Lessons from global drug regulation
Recently, the Indian Ministry of Health and Family Welfare issued a government resolution banning the use of Nimesulide above 100…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Supriya Lifescience ramps up capacity and global readiness for next phase of growth
Supriya Lifescience has built a strong global presence in Active Pharmaceutical Ingredients. What has guided this journey?
Our…
Sharp Sterile Manufacturing increases capacity with $28 million investment
Sharp Sterile Manufacturing has announced a $28 million expansion of its site in Lee, Massachusetts. The enhanced state-of-the-art…
We are cost-competitive and aligned with global ESG framework demands
The biologics sector is very dependent on single-use products and containment solutions. For example, the COVID pandemic exposed…
Sigachi Industries appoints Atul Dhavle as Chief People Officer
Sigachi Industries, a leading global manufacturer of pharmaceutical excipients and active pharmaceutical ingredients (APIs),…
Separate license regime for bulk drugs, API and KSMs, under govt’s consideration
The government is considering a separate licensing framework for bulk drugs, active pharmaceutical ingredients (APIs) and key…
Dr. Reddy’s launches Hevaxin, a novel recombinant Hepatitis E vaccine in India
Dr. Reddy’s Laboratories announced the launch of Hevaxin, a novel recombinant vaccine for the prevention of Hepatitis E virus…
Leadership imperative shaping India’s healthcare and pharma landscape in 2026
India’s healthcare and pharmaceutical industries stand at an inflection point. The sector grew at a remarkable 17.5 per cent CAGR…
Advanced excipients could emerge as India’s next big pharma advantage
When the Central Drugs Standard Control Organization (CDSCO) revised Good Manufacturing Practice norms under Schedule M in…
Pandorum Technologies, Nucelion Therapeutics partner to manufacture exosome-based therapy for ocular…
Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmable tissue…